Sir, The letter by Beattie et al (1984; 53: 349) contains some interesting and remarkable statements, and a few are worthy of comment. The letter states that "the maximum rate of change of ST amplitude was a poor predictor of the extent of coronary artery disease" when using "a computerised Frank orthogonal lead system." This finding is hardly surprising; though the full details of the protocols have not been stated, it seems that this report is yet another that has used methods different from those used in the Leeds test and obtained different results. In Leeds the ST/HR slope, using conventional leads plus lead CM5, gives results after manual measurement that are still consistent with our initial experience; the maximal ST/HR slope is an accurate index of the presence and severity of myocardial ischaemia, which in the patients with anginal pain is assessed and graded according to results of coronary arteriography.
A remarkable feature of the letter on the use of the maximal ST/HR slope is the suggestion that this "assumes that the ST response to exercise is uniform in all leads and that a common pathophysiological mechanism-namely a mismatch of myocardial oxygen supply and demand-is the sole determinant of such a response." Then the letter proceeds to destroy its own suggestion, using the well accepted contention that electrocardiographic changes are influenced by the region of the myocardium in which ischaemia occurs.
Perhaps we might be allowed to state that in our use of the maximal ST/HR slope there is no need for any assumptions to be made; but there are implications of the results. Also our up to date experience with the maximal ST/HR slope is that this slope is an index of myocardial ischaemia; it is still accurate in detecting the ischaemia as assessed by coronary angiography in a selected group of patients with angina, but it seems also in ongoing trials to be an index of myocardial ischaemia in patients without coronary constriction, for example, in patients with a dilated or hypertrophied left ventricle. 
Radiographic contrast agents in angiocardiography
Sir, Hayward and Dawson are to be congratulated on their excellent review of radiographic contrast agents in angiocardiography (1984; 52: 361-8) . Their statement that "the viscosities of the new agents are all appreciably higher than those of conventional agents" is, however, at variance with their Our department adopts Dr Partridge's approach of using a new contrast agent only in selected patients in all radiological procedures requiring an intravascular contrast agent, and it is our impression that most other departments in the United Kingdom adopt this sensible approach. Grainger has made a useful summary of criteria for the selection of such patients. ' As for cardiac radiology in particular, most practitioners in the United Kingdom appear to take the reasonable view that, in good hands, the incidence of serious complications is low and that, though they undoubtedly have strong theoretical advantages, the general use of the new agents is at the moment unjustified on economic grounds. While savings should be made wherever possible without detrimental effect on patients it is pertinent to make the point that the cost of the contrast material, old or new, is only a very small proportion of the total cost of a cardiac study. 
